InvestorsHub Logo

badshah

07/26/17 9:19 AM

#18244 RE: GoodiePop #18243

GoodiePop...I agree partly with what you said...if you have lived through 2 R/Ss and been around for 3 years and are still interested in this equity, first you should take up a sizable positin and forget about your past investment...next, if you truly read the history of this company and the father/son Chang dynasty you should know that the elder Chang and others at Rutgers did a lot of early clinical work and the curent clinical work being carried out in Thailand is for "Phase 1/2 clinical trials for the treatment of AML", Phase 1 being mostly completed while Dr. Chang was still at Rutgers. Now the reason most oldies like me are once again interested in this company (in spite of havy losses in the past) is due to the added indication of Parkinson's disease and the collaboration with hypgen which hopefully puts an end to the toxic convertible dilution...we remain hopeful but fully aware of Ben's past history...

Rory2

07/26/17 10:46 AM

#18256 RE: GoodiePop #18243

It states in a couple of their press releases about phase 1-2 trials forgive me for misunderstanding. I'm not here to blow smoke up anyones a$$ I try to post only facts. And if I'm wrong I'm always open for correction. I'm not on here to pump bs. I'm just trying to help bring info to the board.